MedPath

A clinical trail to study the effect of drug LAVANKATHI CHOORANAM on Iya iraippu noi Bronchial Asthma

Phase 2
Recruiting
Conditions
IYA IRAIPPU NOI BRONCHIAL ASTHMA
Registration Number
CTRI/2018/04/013233
Lead Sponsor
Prof Dr S Neelavathi
Brief Summary

The Study is Prospective open labled Randomized Phase - II Clinical Trail to Evaluate the Therapeutic Efficacy of Trail Drug LAVANKATHI CHOORANAM 6g bd for 20 days on the 40 Patients with IYA IRAIPPU NOI that will be conducted in Government Siddha Medical College and Hospital Palayamkottai. The Primary Out come Therapeutic efficacy of LAVANKATHI CHOORANAM The Secondary will be the Evalution of Siddha Diagnostic Parameters.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Difficulty in Breathing Tightness of Chest Wheeze.
  • Add Sound (Rhonchi) Cough without Expectoration H/O Allergy, Sneezing PEFR Male.
  • From 250 l/min to 150 l/min Female.
  • From 250 l/min to 100 l/min Spirometer Study.
Exclusion Criteria

Cardiac Diseases Renal Desease Tuberculosis COPD Status Asthmaticus Diabetes Mellitus hypertension Pragnancy Lactating Mothers.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate the Therapeutic efficacy of LAVANKATHI CHOORANAM in the Treatment of IYA IRAIPPU NOI20 Days
Secondary Outcome Measures
NameTimeMethod
To Evaluate the Siddha Cofactor Toword the Efficacy of the Traial Drug in the LAVANKATHI CHOORANAM and to Evalute the Pharmacological Action40

Trial Locations

Locations (1)

Government Siddha Medical College and Hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Government Siddha Medical College and Hospital
🇮🇳Tirunelveli, TAMIL NADU, India
DR S SOWMIYA
Principal investigator
9894132112
sowmiyascv@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.